TCL Archive Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program November 29, 2002
TCL Archive Blood Test Could Predict Relapse, Survival For Children, Young Adults With Leukemia May 25, 2007
TCL Archive FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer. July 27, 2007
TCL Archive New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial September 24, 2010
TCL Archive Clearinghouse Finds Three Chemicals Pose Risk Of Cncer to Humans; 38 More Will Go On Test August 5, 1977
